The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty
Authors:
- Valentin FusterVFValentin Fuster
- Douglas IsraelDIDouglas Israel
- Lina BadimonLina Badimon
- Juan BadimonJBJuan Badimon
- James H. ChesebroJCJames H. Chesebro
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty AcidsNew England Journal of Medicine, 1988
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Percutaneous Transluminal Coronary Angioplasty in 1985–1986 and 1977–1981New England Journal of Medicine, 1988
- A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Inhibition of Atherosclerosis by Cod-Liver Oil in a Hyperlipidemic Swine ModelNew England Journal of Medicine, 1986
- Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1985
- Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.Circulation, 1984
- Morphology after Transluminal Angioplasty in Human BeingsNew England Journal of Medicine, 1981
- LOCALIZATION OF EARLY ATHEROSCLEROTIC LESIONS IN AN ARTERIAL BIFURCATION IN HUMANSActa Pathologica Microbiologica Scandinavica Section A Pathology, 1981
- Nonoperative Dilatation of Coronary-Artery StenosisNew England Journal of Medicine, 1979